Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.

Familial cancer - 1 Jan 2009

Kadouri Luna, Temper Mark, Grenader Tal, Abeliovich Dvorah, Hamburger Tamar, Peretz Tamar, Lotem Michal

Abstract excerpt

INTRODUCTION: Several epidemiologic studies have provided suggestive evidence of a link between coetaneous malignant melanoma (CMM) and breast cancer. The Breast Cancer Linkage Consortium (BCLC) reported approximately 2.6-fold increase in the risk for CMM among BRCA2 carrier families. METHODS: To evaluate the role of BRCA1/2 mutations in CMM, we screened 92 Jewish patients of Ashkenazi origin diagnosed with CMM...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Founder Effect

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Melanoma

Share to Skin Neoplasms

Share to White People

Source

Identifiers

PMID: 18679827
DOI: 10.1007/s10689-008-9206-8

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.PMID 18679827Read ↗

Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.Semantic proximity Read ↗

Search for genetic variants associated with cutaneous malignant melanoma in the Ashkenazi Jewish population.Semantic proximity Read ↗

The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations.Semantic proximity Read ↗

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.Semantic proximity Read ↗

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.Semantic proximity Read ↗

The frequency of founder mutations in theBRCA1,BRCA2, andAPC genes in australian Ashkenazi JewsSemantic proximity Read ↗

Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.Semantic proximity Read ↗

Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.